期刊文献+

串珠素反义cDNA对人喉癌裸鼠移植瘤的抑制作用

Growth inhibition effection of perlecan anti-sense cDNA on human laryngeal carcinoma xnograft in nude mice
原文传递
导出
摘要 目的:研究串珠素(perlecan)反义cDNA质粒(pAP)对喉癌Hep-2细胞裸鼠移植瘤的影响。方法:应用pAP转染喉癌Hep-2细胞,建立人喉癌裸鼠移植瘤模型,观察裸鼠移植瘤的生长速度。分为3组:未转染的Hep-2细胞组(WT组)、空载体phβApr-neol转染组(neo组)及pAP转染组(pAP组)。用RT-PCR和免疫组织化学方法检测各组裸鼠移植瘤的perlecan mRNA和蛋白质的表达情况。结果:肿瘤生长4周后,WT组和neo组裸鼠移植瘤的平均体积较大,pAP组裸鼠移植瘤的平均体积较小,差异有统计学意义(P<0.01)。perlecan mRNA在WT组和neo组高表达,在pAP组低表达,均差异有统计学意义(均P<0.05)。perlecan蛋白在WT组和neo组高表达,定位于癌细胞的细胞核和细胞质,在pAP组低表达,均差异有统计学意义(均P<0.01)。结论:pAP对喉癌Hep-2细胞裸鼠移植瘤的发生、发展有重要影响。 Objective:To observe growth inhibition effectof perlecan anti-sense cDNA(pAP) on human laryn- geal carcinoma xnografted in nude mice. To vertify its antitumor effect and mechanism in vivo, and it may be useful as a biomarker in carcinoma of larynx cancer. Method.. Created the model of human laryngeal carcinoma xnograft in nude mice. To observe growth of those xnografts in nude mice and draw growth curve of xnografted. The expression of perlecan mRNA and portein in xnografts were examined by RT-PCR and immunohistochemistry. Result:Volume of xnografts in the group transfected by the plasmids of pAP were significant small as compared with other two groups made by the wild type cells and phβApr-neol cells (P〈0.05). It was showed that the expression of perlecan mRNA and protein were significantly reduced in the tumor of pAP transfected Hep-2 cells as compared with the tumors transfected by the wild type cells and phβApr-neol cells (P〈0.01). Conclusion.. These data raise the possibility that pAP many play key roles in the growth of those xnografts in nude mice.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2014年第17期1326-1329,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 串珠素 反义CDNA 喉肿瘤 perlecan anti-sense cDNA laryngeal carcinoma
  • 相关文献

参考文献12

  • 1SMOLLE E, TAUCHER V, PETRU E, et al. Tar- geted treatment of ovarian cancer -the muttiple-kinase- inhibitor sorafenib as a potential option[J]. Antican- cer Res, 2014, 34:1519-1530.
  • 2KARAMAN S, DETMAR M. Mechanisms of lymphatic metastasis[J]. J Clin Invest, JIANG X,COUCHMAN J 2014, 124: 922-928.
  • 3R. Perlecan and tumor an giogenesis[J]. J Histochem Cytochem, 2003, 51 1393-1410.
  • 4陈广理,龚树生,丁娟,刘英鹏,罗凌惠,王建亭,陈沛,鄢开胜.串珠素反义cDNA质粒转染对喉癌细胞Hep-2增殖能力的影响[J].临床耳鼻咽喉科杂志,2006,20(21):984-987. 被引量:1
  • 5MARCHISONE C, DEL GROSSO F, MASIELLO L, et al. Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan[J]. Pathol On- col Res, 2000, 6: 10-17.
  • 6GOYAL A, PAl. N, CONCANNON M, et al. En- dorepellin, the angiostatic module of perlecan, inter- acts with both the a2 :1 integrin and vascular endothe- lial growth factor receptor ceptor antagonism [J]. J 25947-25962. 2 (VEGFR2): a dual re- Biol Chem, 2011, 286:
  • 7GUSTAFSSON E, ALMONTE-BECERRIL M, BLOCH W, et al. Perlecan maintains microvessel in- tegrity in vivo and modulates their formation in vitro[J]. PLoS One, 2013, 8:e53715-e53715.
  • 8陈广理,丁娟,罗凌惠,刘英鹏,鄢开胜,陈沛,宋鹏,付勇,龚树生.血管内皮生长因子及受体在喉癌细胞Hep-2中的表达及意义[J].临床耳鼻咽喉科杂志,2005,19(18):842-844. 被引量:2
  • 9陈广理,丁娟,罗凌惠,刘英鹏,鄢开胜,陈沛,宋鹏,付勇,王建亭,龚树生.串珠素在喉癌细胞Hep-2中的表达[J].临床耳鼻咽喉科杂志,2006,20(2):78-80. 被引量:4
  • 10陈广理,罗凌惠,丁娟,刘英鹏,王建亭,龚树生.喉鳞癌中碱性成纤维细胞生长因子及其双受体系统的研究[J].中华耳鼻咽喉头颈外科杂志,2006,41(4):301-302. 被引量:2

二级参考文献23

  • 1鲁海涛,龚树生.喉癌中环氧化酶-2和p53的表达及相关性研究[J].临床耳鼻咽喉科杂志,2004,18(7):421-423. 被引量:4
  • 2Xiao-YiSun Zai-DeWu Xiao-FengLiao Ji-YanYuan.Tumor angiogenesis and its clinical significance in pediatric malignant liver tumor[J].World Journal of Gastroenterology,2005,11(5):741-743. 被引量:8
  • 3陈广理,丁娟,罗凌惠,刘英鹏,鄢开胜,陈沛,宋鹏,付勇,王建亭,龚树生.串珠素在喉癌细胞Hep-2中的表达[J].临床耳鼻咽喉科杂志,2006,20(2):78-80. 被引量:4
  • 4Ghiselli G, Eichstetter 1, Iozzo R V. A role for the perlecan protein core in the activation of the keratinoeyte growth factor receptor. Biochem J, 2001, 359:153-163.
  • 5Aviezer D, Levy E, Safran M, et al. Differential strucrural reqnirements of heparin and heparan sulfate proteoglyeans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem, 1994, 269:114-121.
  • 6Jiang X, Couchman J R. perlecan and tumor angiogenesis. J Histochem Cytochem,2003,51:1393-1410.
  • 7Marchisone C,Del Grosso F, Masiello L,et al. Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan. Pathol Oneol Res, 2000, 6:10-17.
  • 8Ribatti D. The crucial role of vascular permeability factor/vaseular endothelial growth factor in angiogenesis: a historical review. Br J Haematol, 2005,128 : 303-309.
  • 9Iozzo R .V,San Antonio J D. Heparan sulfate proteoglycans:heavy hitters in the angiogenesis arena. J Clin Invest,2001,108:349-355.
  • 10Kurokawa H, Katsube K, Podyma K A, et al. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts. Cancer Sci, 2003,94:277-285.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部